A global view of MS

December 2006
Inside MS;Dec2006/Jan2007, Vol. 24 Issue 6, p37
Academic Journal
The article features the launch of a free online Atlas of MS by the Multiple Sclerosis International Foundation in 2006. The online service contains facts about the number of people with multiple sclerosis around the world, and the availability of resources to diagnose, inform, treat, support, and care for them are centrally organized. Presented in maps, pie charts, and graphs, the Atlas confirms that resources vary widely.


Related Articles

  • Progression is unpredictable. Luebeck, Jack // Momentum (19403410);Summer2011, Vol. 4 Issue 3, p32 

    A personal narrative is presented which explores the author's experience of being diagnosed with progressive multiple sclerosis at age 46.

  • Managing multiple sclerosis. Robinson, Gina // Independent Nurse;9/6/2010, p32 

    The article reports on the management of multiple sclerosis (MS). It refers to a condition of the central nervous system (CNS) wherein the myelin sheath are damaged. Some of the symptoms are visual disturbances, continence issues and sexual dysfunction. Currently, there are no treatments for MS...

  • Managing Multiple Sclerosis: Maximizing Diagnosis and Treatment to Improve Patient Outcomes. Jung, Lily // Journal of Managed Care Medicine;2011, Vol. 14 Issue 4, p32 

    Multiple sclerosis is a disease in which permanent neurologic damage accumulates with each attack of symptoms. Disease modifying therapy reduces the rate of relapse and thus decreases the amount of accumulated disability. Early initiation of therapy is key to maximizing the ultimate amount of...

  • Modern approaches to multiple sclerosis. Wilson, Martin // Clinical Medicine;Aug2011, Vol. 11 Issue 4, p361 

    The article discusses modern approaches to diagnosis and treatment of multiple sclerosis (MS), a common cause of neurological disability. MS has several subtypes which include relapsing-remitting MS (RRMS), progressive-relapsing MS and secondary progressive MS (SPMS). The use of magnetic...

  • Diagnosis and Management of Multiple Sclerosis. Calabresi, Peter A. // American Family Physician;11/15/2004, Vol. 70 Issue 10, p1935 

    Focuses on multiple sclerosis (MS). Signs and symptoms; Basis for the diagnosis of MS; Symptomatic therapies for MS; Drugs for the initial management of MS that are available in the U.S.

  • National MS registries. Flachenecker, Peter; Stuke, Kristin // Journal of Neurology;Dec2008 Supplement 6, Vol. 255, p102 

    This review gives an overview of national registries that are currently in use for patients with multiple sclerosis (MS). The large-scale registries described herein include the Danish MS Registry, the Norwegian MS Registry, the Swedish MS Registry, the Italian MS Database Network, the...

  • Síndrome de retirada abrupta de baclofeno intratecal: A propósito de un caso. Corrales-Arroyo, María Jesús; López-Gallardo, Gema; Del Real-Francia, María Ángeles // Revista Mexicana de Neurociencia;may/jun2014, Vol. 15 Issue 3, p175 

    INTRODUCTION: Intrathecal baclofen (ITB) treatment is increasingly used in cases of severe spasticity. It is very important to know the eventual complications that can appear during the therapy. OBJECTIVE: TO emphasize the importance of an early identification of symptoms and differential...

  • Effective communication at the point of multiple sclerosis diagnosis. Solari, Alessandra // Multiple Sclerosis Journal;Apr2014, Vol. 20 Issue 4, p397 

    As a consequence of the current shortened diagnostic workup, people with multiple sclerosis (PwMS) are rapidly confronted with a disease of uncertain prognosis that requires complex treatment decisions. This paper reviews studies that have assessed the experiences of PwMS in the peri-diagnostic...

  • Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon β-1b. Lazzaro, Carlo; Bianchi, Cosetta; Peracino, Lucia; Zacchetti, Paola; Uccelli, Antonio // Neurological Sciences;Feb2009, Vol. 30 Issue 1, p21 

    New therapeutic options have modified the natural history and health care costs of multiple sclerosis (MS). An epidemiological 25 years-long model-based cost-utility analysis was performed following the Italian National Health Service (INHS) and societal perspectives to compare costs and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics